Loading
Latest filing published 22 Apr 2019 for Clementia Pharmaceuticals Inc., €1.7M.
No signal scores available.
Francois Nader appears in our data through filings on Clementia Pharmaceuticals Inc. shares, published by SEDI. In total, 2 filings cover trades dated from 14 August 2017 to 17 April 2019.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 22 April 2019 came the latest disclosure, a transaction for €1.7M in Clementia Pharmaceuticals Inc. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations